T2 Biosystems Inc. plans to sell 5,650,000 common shares as part of an underwritten registered public offering.
The Lexington, Mass.-based diagnostic company also plans to grant its underwriters an option to buy up to an additional 847,500 shares.
Leerink Partners LLC is acting as joint book-running manager for the offering. Canaccord Genuity LLC is acting as passive book-running manager. Janney Montgomery Scott LLC, JonesTrading Services LLC and WBB Securities LLC are acting as co-managers for the offering.
